Cargando…
Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has become a prevalent cause of chronic liver disease and ranks third among the causes of transplantation. In the United States alone, annual medical costs are approximately 100 billion dollars. Unfortunately, there is no Federal Drug Administrat...
Autores principales: | Tidwell, Jasmine, Balassiano, Natalie, Shaikh, Anjiya, Nassar, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494562/ https://www.ncbi.nlm.nih.gov/pubmed/37701920 http://dx.doi.org/10.4254/wjh.v15.i8.1001 |
Ejemplares similares
-
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011) -
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Biciusca, Teodora, et al.
Publicado: (2023) -
Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
por: Zhu, Jin-Zhou, et al.
Publicado: (2016) -
Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
por: Tovo, Cristiane V, et al.
Publicado: (2017) -
The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021)